Table 1.
Demographics of patients operated on for rectovaginal fistula (RVF).
| Patient ID | Age (years) | Duration of CD (years) | Duration of RVF (years) | No. of tracts | No. of previous surgeries* | Previous medication | Ongoing medication | PDAI | CDAI | Reoccurrence (days) |
|---|---|---|---|---|---|---|---|---|---|---|
| 1 | 56 | 25 | 2 | 1 | 0 | Corticosteroids | Adalimumab, mesalamine | 6 | 196 | – |
| 2 | 66 | 40 | 2 | 1 | > 3 | Prednisolone | Ayurvedic medication | 15 | 208 | 19 |
| 3 | 32 | 11 | 3 | 1 | > 3 | Corticosteroids, infliximab, adalimumab, azathioprine, mesalamine, ustekinumab | Azathioprine, mesalamine | 10 | 177 | 10 |
| 4 | 48 | 11 | 3 | 1 | 2 | Azathioprine, mesalamine, sulfasalazine, infliximab, prednisolone | Azathioprine, mesalamine, sulfasalazine, infliximab | 5 | 81 | 42 |
CD, Crohn’s disease; CDAI, Crohn's Disease Activity Index; PDAI, Perianal Disease Activity Index.
*
Crohn's disease and RVF‐related surgeries.